A large number of studies have shown that abnormal epigenetic modifications can affect the occurrence and development of cancer by regulating cancer MR (Wang et al., 2022; Yang J. et al., 2023; Yu et al., 2018). The gene discussed is NR3C2; the disease is cancer.